Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer: A multi-centre retrospective analysis.

Sarah Hunter, Eleni Karapanagiotou, Karim El-Shakankery et al.|Journal of Clinical Oncology|2017

Cited by 1